Introduction {#sec1}
============

Fragile-X syndrome (FXS, MIM300624) is the most common form of mental retardation in the human population. This affects approximately 1/7,000 males and 1/11,000 females ([@ref74]), and patients exhibit intellectual disability, autism, hyperactivity, long face, large ears, language delay, hyper arousal anxiety ([@ref81]; [@ref124]; [@ref150]) macroorchidism, and malformed spermatids ([@ref81]; [@ref160]). The most frequent cause of the syndrome is a CGG trinucleotide repeat expansion (greater than 200 repeats) in the 5′ of the Fragile-X locus in Xq27.3, which leads to the hypermethylation of the gene promoter. The final effect is the transcriptional silencing of the Fragile-X Mental Retardation (*Fmr1*) gene, with a consequent loss of the encoded FMRP protein ([@ref64]). FMRP is a complex protein that displays distinct motifs: a nuclear localization signal (NLS) and a nuclear export signal (NES), two tandem Tudor domains that are likely involved in protein-protein interactions and/or in the DNA binding, as well as three RNA-binding domains including two KH domains and one Arg-Gly-Gly (RGG) box ([Figure 1](#fig1){ref-type="fig"}) ([@ref124]; [@ref141]; [@ref150]). In mammals, FMRP is nearly ubiquitous, but it is heavily expressed in neurons, particularly in the cortex, hippocampus, and Purkinje cells where it regulates specific messenger targets. FMRP is also expressed at high levels in testes. Accordingly, the main effects of the FMRP loss in humans are in the nervous system and in the gonads ([@ref150]). In neurons, the absence of FMRP may alter the processing, the localization, and/or the translational regulation of mRNAs encoding pre- and postsynaptic proteins. These defects can account for the abnormal maturation of dendritic spines in FXS patients, which are longer, thinner, and denser than the normal ones ([@ref169]; [@ref13]; [@ref107]), representing the cellular defects underpinning the neuronal dysfunctions characterizing the Fragile-X disorder.

![Conserved domains of FMRP/dFmr1 proteins. The drawings are not to scale; the exact positions of the amino acids are indicated; the domains are indicated with different colors.](fgene-10-00010-g001){#fig1}

In addition to CGG triplet expansion, different mutations in the *Fmr1* gene, leading to FXS, have been reported. They include deletions and missense and nonsense mutations, which are listed in the Human Gene Mutation Database for FXS[^1^](#fn4){ref-type="fn"}. Mutations occur all along the coding sequences and affect different domains, which may explain why the FraX patients display common as well as specific defects ([@ref143]; [@ref150]; [@ref5]; [@ref125]; [@ref167]; [@ref138]).

Two autosomal homologs of *Fmr1* have been identified in the human genome: the Fragile-X mental retardation autosomal homolog 1 (FXR1) and 2 (FXR2), together with the *Fmr1* gene, form the Fragile-X gene family ([@ref158]; [@ref196]). Both homologs encode for RNA-binding proteins, FXR1P and FXR2P, with similar and/or complementary functions to those of FMRP, respectively ([@ref131]; [@ref10]).

A particular aspect linked to FXS is that individuals with a number of CGG repeats from 55 to 200 present a condition known as premutation and display an increased amount of *Fmr1* mRNA. It was proposed that the symptoms, exhibited by these subjects, are related to the *Fmr1* mRNA overproduction. Males with the premutation are at risk to developing Fragile-X-associated tremor/ataxia syndrome (FXTAS, MIM300623), whereas females with the premutation have an increased probability to develop Fragile-X-associated primary ovary insufficiency (FXPOI) ([@ref6]; [@ref88]; [@ref146]).

The function of FMRP has been primarily studied in the nervous system of mammals and *Drosophila*, focusing on its role as a translational regulator acting: either by repressing translational initiation ([@ref153]; [@ref121]; [@ref4]) or by interacting with the translating ribosomes ([@ref159]; [@ref170]; [@ref56]; [@ref76]; [@ref42]). It has also been proposed that FMRP may exert its translational control through the miRNA pathway ([@ref159]; [@ref29]; [@ref76]; [@ref80]; [@ref188]). Many screenings, aiming at identifying FMRP targets (mRNAs and proteins), contributed to the understanding of the role of FMRP, mainly in the nervous system. Many of these targets are involved in synaptic activity, which may account for the FXS phenotypes, such as defects in the development of neuronal architecture and in synaptic dysfunction ([@ref43]; [@ref10]).

FMRP regulates the local translation of a subset of mRNAs at synapses following the activation of the metabotropic glutamate receptors (mGluRs) ([@ref73]; [@ref16]; [@ref109]). Deregulation of local protein synthesis is considered a core mechanism in FXS, underlying altered synaptic plasticity and consequent cognitive impairment. The role of FMRP in the regulation of translation was better characterized in the Drosophila quiescent oocyte in which the translation of stored mRNAs is a crucial point for the correct development of embryos ([@ref63]).

Animal models of FXS have been developed in zebrafish, mouse, and rat ([@ref178]; [@ref109], [@ref108]; [@ref71]). Over the last decades, *Drosophila* has also provided key contributions to further understand the molecular pathways defective in FXS, thanks to the many advantages in the use of this versatile organism ([@ref173]; [@ref155]; [@ref50]; [@ref45]). The resulting imprecise excisions provided *Fmr1* alleles that lack dFmr1 expression, a situation comparable to the loss of function mutations observed in FXS patients ([@ref182]). dFmr1 is equally similar to the three mammalian gene products (\~35% identity, \~60% similarity) and shows particularly high sequence conservation (\~70% identity) in critical domains such as the Tudor/Agenet domain that is involved in DNA binding, the RNA-binding domains, and the nuclear localization signals ([@ref192]; [@ref193]; [@ref188]).

The *Drosophila melanogaster* dFmr1 protein is expressed from embryonic stages to adult, and it is enriched in the nervous system ([@ref113]). In the brain, dFmr1 is highly expressed in the mushroom bodies, the main structure of the brain involved in cognitive functions. dFmr1 highly accumulates in the dendrites and in the axons of Kenyon cells, the intrinsic neurons of the mushroom bodies ([Figure 2A](#fig2){ref-type="fig"}). Its expression is ubiquitous in the neurons of the adult brain, whereas very low levels have been detected in glial cells ([@ref182]; [@ref197]; [@ref113]; [@ref33]). Outside the nervous system, dFmr1 is presented at a high level in larval and adult testes with a strong expression in spermatocytes ([@ref198]; [@ref24]). dFmr1 is also a component of the polar granules of the embryo where it interacts with other specific proteins present in these structures such as Vasa, Cup, and Hsp83 ([@ref181]; [@ref41]; [@ref135]; [@ref90]).

![Schematic of different body parts of a *Drosophila melanogaster* adult. **(A)** Head, the mushroom bodies are indicated. **(B)** Upper part: ovariole; lower part: immunolabeling of a stage 2 oocyte; the white arrow indicates the perinuclear nuage. **(C)** Upper part: adult testis; lower part: immunolabeling of the apical part of the testis is indicated; the white arrow indicates the perinuclear nuage.](fgene-10-00010-g002){#fig2}

The *Drosophila* animals that completely lack dFmr1 recapitulate many of the phenotypes exhibited by patients with the Fragile-X syndrome. At the cellular level, mutants present defective neuronal architecture and synaptic function. The neurons of *dFmr1* null mutant animals exhibit abnormally organized synapses in both the peripheral and central nervous systems. The neuromuscular junctions (NMJs) of the *Drosophila* larva are simple synapses that represent a good model to study synaptic plasticity. The lack of *dFmr1* causes pronounced synaptic overgrowth at the NMJs ([@ref197]; [@ref153]; [@ref127]). Mutant flies display altered behaviors, such as reduced courtship activity of males and irregular circadian rhythms, like the eclosion timing, even though the mRNAs for the two clock elements Per and Tim are not affected. In addition, *dFmr1* mutants exhibit defects in locomotor activity and an acute impairment of long-term memory ([@ref156]; [@ref46]; [@ref113]; [@ref20], [@ref21]).

In the ovary, dFmr1 plays a role in translational regulation ([@ref35]), where it controls germ stem cell differentiation through the miRNA-mediated pathway ([@ref189]) and cell proliferation through the proto-oncogene *cbl* ([@ref52]).

Interestingly, dFmr1 is also involved in the piRNA pathway in the *Drosophila* gonads as well as in the DNA damage response in *Drosophila* and mouse ([@ref195]; [@ref5]; [@ref24]) These findings provide a direct link between dFmr1/FMRP (from here onward, we will name dFmr1 the Drosophila protein as FMRP the mammalian protein) and genome instability, which may represent the common denominator for the multiple phenotypes described in the Fragile-X syndrome and in animal models for the disease.

In this review, we will predominantly treat the roles of dFmr1 related to the genome instability in the gonads and in the nervous system.

The Role of dFmr1 in the piRNA Pathway {#sec2}
======================================

*dFmr1* Mutations Affect the Regulation of the *Crystal-Stellate* System and of the Transposable Elements in the Gonads {#sec3}
-----------------------------------------------------------------------------------------------------------------------

In 2015, our group demonstrated, for the first time, the role of dFmr1 in the piRNA-mediated silencing of transposable elements and repetitive sequences in the *Drosophila* gonads ([@ref24]). Piwi-interacting RNAs or piRNAs are small RNA molecules protecting animal germ cells and their somatic precursors from the insertion of transposons and other repetitive elements hence preserving genome stability ([@ref103]; [@ref130]; [@ref199]; [@ref7]; [@ref163]). The genomic clusters that act as sources of piRNAs contain multiple and also defective transposon sequences. Most of the piRNA clusters produce piRNAs from both genomic strands, and the other clusters produce piRNAs only from one genomic strand.

The molecular mechanism underlying the silencing of transposable elements reached a deep level of knowledge following studies performed in the ovaries. Argonaute proteins, belonging to the Piwi subfamily groups (P-element-induced Wimpy Testes or Piwi, Aubergine or Aub, and Ago3), play a crucial role in these processes ([@ref201]). Aub and Ago3 localize to the nuage ([Figure 2B](#fig2){ref-type="fig"}), a perinuclear structure found in animal germ cells. Piwi localizes predominantly in the nucleus of both germ and somatic cells of the ovary.

Two pathways for piRNA biogenesis and function have been established the primary and the ping-pong pathways ([Figure 3](#fig3){ref-type="fig"}) ([@ref201]; [@ref103]).

![Schematic of the piRNA's biogenesis. Somatic and germline pathways are indicated. Zuc stands for Zucchini protein (see text). In the germline pathway, Qin is a partner of Vasa, which behaves like a molecular platform for the piRNA pathway (see text and [@ref163]).](fgene-10-00010-g003){#fig3}

In the primary pathway, transcript precursors, arising from specific genomic clusters, are processed into primary piRNAs that are bound by specific Piwi proteins. *Drosophila* ovarian somatic cells use exclusively the primary pathway. In these cells, the process occurs in perinuclear Yb bodies, which are discrete cytoplasmic compartments that take their name from the principal player in the process, the protein Yb, in the somatic cells of the ovary and testis ([@ref168]). piRNA factors, such as Armitage, Shutdown, and Vreteno, accumulate in the Yb bodies. Upon the formation of the 3′ end of the precursors by Zucchini, the mature primary piRNAs are loaded onto Piwi, which then enters the nucleus and induces transcriptional transposon silencing ([@ref149]).

Germ cells use predominantly the ping-pong amplification process in which the primary piRNAs are subjected to an amplification loop that increases their amount. In this case, the Piwi subfamily proteins, Aub and Ago3, bind the piRNAs and use the sequence homology to recognize the corresponding transposon transcript. Aub and Ago3 cooperate in the ping-pong pathway to amplify the piRNAs ([@ref201]).

The primary and the ping-pong pathways are also present in *Drosophila* testes ([Figure 2C](#fig2){ref-type="fig"}). In this tissue, the most abundant piRNAs associated with Aub and Ago3 correspond to the "*crystal*" piRNAs ([@ref9], [@ref8]; [@ref180]; [@ref122]; [@ref22]). The *crystal-Stellate* system represents the first reported natural case of piRNA-mediated regulation, where the repetitive euchromatic *Stellate* sequences are silenced by the piRNAs produced by the heterochromatic *crystal* locus. *Stellate* and *crystal* are composed of tens to hundreds of copies of repetitive sequences organized in tandem ([@ref98]; [@ref126]; [@ref19]; [@ref177]; [@ref51]; [@ref22]). At the molecular level, the loss of the *crystal* region or the "loss of function" mutations of genes involved in the *crystal-Stellate* regulation, called *crystal-Stellate* modifiers, results in the production of a testes-specific *Stellate* mRNA of 750 bases, coding for the Stellate protein. This results in the formation of needle or star-shaped crystalline aggregates that can be revealed by using a specific antibody ([@ref23]). The phenotype induced by *crystal-Stellate* misregulation has provided an efficient tool to identify several genes involved in the piRNA pathway. The majority of the *crystal-Stellate* modifiers has a role in the silencing of germinal and somatic transposons and participates in the primary as well as in the ping-pong pathway. Interestingly, mutants for these genes affect fertility, at various degrees, both in females and males ([@ref128]; [@ref161], [@ref163]; [@ref162]; [@ref22]; [@ref148]).

Null *dFmr1* mutations affect the piRNA pathway in the gonads and the fertility of males and females ([@ref198]; [@ref24]). In the mutant testes, the levels of the "*crystal*" specific piRNAs are reduced, leading to the formation of the crystalline aggregates. In addition, dFmr1 was demonstrated to have a role in the piRNA-mediated silencing of both germline and somatic transposable elements (TEs) ([@ref24]). For all these reasons, dFmr1 should be considered as a *bona fide* component of the piRNA pathway, at least in the gonads. More recently, the role in the silencing of TEs was confirmed by the work of Jiang et al. who demonstrated that the expression of selfish genetic elements increases in the ovaries of *dFmr1* mutant females ([@ref79]).

dFmr1 Genetic and Biochemical Interaction With Argonaute Proteins in the Gonads and in the Nervous System {#sec4}
---------------------------------------------------------------------------------------------------------

The Argonaute proteins are key players of the small RNA-mediated silencing pathway, being the components of the RNA-induced silencing complex (RISC). By using small RNA molecules, they mediate the post-transcriptional control of repetitive sequences, transposons, and genes in different tissues ([@ref82]; [@ref25]; [@ref87]; [@ref200]; [@ref94]; [@ref103]). The *Drosophila melanogaster* genome contains five genes coding for proteins of Argonaute family: Ago1 and Ago2 belong to the Ago subfamily and work in the miRNA (micro RNA) and siRNA (small interfering RNA) pathways. As mentioned above, Ago3, Piwi, and Aub act predominantly in the gonad-specific piRNA pathway ([@ref94]; [@ref175]).

Ago1 is commonly associated to the miRNA pathway, but data from our lab assign to this protein an additional role in the piRNA pathway as well. Indeed, Ago1 affects the silencing of the transposons in the gonads of both sexes, is involved in *crystal-Stellate* regulation in the *Drosophila* testis ([@ref24]; [@ref163]), and localizes at the "nuage" in the subcellular compartment in which other piRNA components localize, at least in testes ([@ref84]; [@ref119]). Accordingly, an Ago1-mediated function was demonstrated to be required for the formation of piRNAs in follicle cells, linking together the two pathways ([@ref116]). The Ago1 protein, hence, has a promiscuous role in small RNA regulation.

A strong argument supporting the role of dFmr1 in the small RNA-mediated pathways is the finding that dFmr1 interacts with the Argonaute proteins. One of the first evidence was provided by the biochemical interaction of dFmr1 with Ago2 and with the components of the RISC in S2 *Drosophila* cells ([@ref29]; [@ref76]).

Since this discovery, many efforts were made to clarify the molecular role of FMRP in the RNA-mediated silencing pathways based on the genetic and biochemical interactions with the Argonaute proteins. Almost all the Argonaute proteins of both subfamilies have been connected to dFmr1 in the gonads as well as in the nervous system. We here present the main findings related to the specific role of FMRP in the small RNA pathways in the two tissues, disclosing multifaceted connections.

dFmr1 interacts with Ago1 and with the *bantam* microRNA in the *Drosophila* ovary to regulate the fate of germline stem cells ([@ref189], [@ref190]). Ago1 was also implicated in terminal dendrites elongation ([@ref93]) and is required for a correct function of dFmr1 at the NMJ ([@ref80]; [@ref24]).

dFmr1 also interacts genetically with Aub, whose overexpression in the germline, as well as in the somatic tissues of the *dFmr1* mutant animals, rescues the phenotypes related to the regulation of transposable elements and to the *crystal-Stellate* interaction mediated by piRNAs ([@ref24]). dFmr1 is widely distributed in the gonads, and it overlaps with Aub at the nuage and at the "piRNA nuage giant bodies" (piNG bodies) ([Figure 4](#fig4){ref-type="fig"}), a giant structure in the nuage of testes where the piRNA components are located and function ([@ref24]). The biochemical interaction between dFmr1 and Aub, in S2 cells, also supports the data obtained with the genetic experiment ([@ref24]). Aub and dFmr1 were demonstrated also to genetically interact in the larval neuromuscular junctions, as the neuronal overexpression of *aub* rescues the *dFmr1* defective NMJs ([@ref24]). Since the presence of Aub in the nervous system is still debated (see the following paragraphs), it has been proposed that the overexpressed Aub may work by taking on the function of Ago1, a protein that is definitely present and has a well-studied role in the nervous system ([@ref93]).

![dFmr1 and Vasa immunolocalization in wt (wild type) adult testes. **(A)** Single confocal section of a wt testis labeled with anti-dFmr1, **(B)** anti-Vasa, and **(C)** merge; magnification 40×. **(D)** Photographic zoom of the cells indicated by arrow in **(C)**; the white arrowhead shows the colocalization of dFmr1 and Vasa in the piNG body.](fgene-10-00010-g004){#fig4}

Another crucial Argonaute interactor of dFmr1 is Piwi. A recent study from Jiang et al. in 2016 reported that dFmr1 and Piwi are present in the same complex in ovarian extracts and act together in the piRNA-mediated transcriptional silencing on the transposable elements in both somatic and germline tissues of the *Drosophila* ovary ([@ref79]). *dFmr1* mutations also influence the amount of a specific piRNA regulating the *roo* transposable elements. The N-terminal region of dFmr1, where the Tudor/Agenet domain is present ([@ref141]; [@ref3]; [@ref24]; [@ref77]), is required for the interaction with Piwi.

Finally, no interaction has been reported between dFmr1 and mammalian FMRP with Ago3, another Argonaute protein that operates in the biogenesis of piRNAs in combination with Aubergine ([@ref94]).

piRNA-Related dFmr1 Interactors Other Than Argonaute Proteins {#sec5}
-------------------------------------------------------------

The role of dFmr1 in the piRNA pathway is supported by its interaction with other components of the piRNA pathway, including Vasa, which is considered a molecular platform for the key components of the piRNA machinery, the so-called Amplifier complex ([@ref187]; [@ref163]). [Figure 4](#fig4){ref-type="fig"} shows the colocalization of dFmr1 and Vasa at the nuage in testes, in particular at the piNG bodies. Emblematic examples have been described above where the direct interaction with four Argonaute proteins has been reported.

The zinc finger protein RP-8 (Zfrp8) also stands out as a very interesting interactor of dFmr1, even though its role in the piRNA pathway or in the human syndrome is still poorly understood.

Zfrp8 was initially identified for its fundamental role in the lymph glands, the site of larval hematopoiesis in *Drosophila* ([@ref111]). In this tissue, Zfrp8 controls cell proliferation. Zfrp8 has also an essential role in follicle cells and in germline ([@ref112]; [@ref110]). This function is conserved during evolution, and the vertebrate Zfrp8 homolog, Pdcd2, is required for stem cell maintenance ([@ref115]; [@ref66]). Zfrp8 genetically interacts with several components of the piRNA pathway in the ovary including *vasa, ago3, spindle-E*, and *squash* ([@ref166]; [@ref128]; [@ref94]; [@ref90]; [@ref172]). In addition, the distribution of Maelstrom, one of the known components of the piRNA pathway, is strongly affected in *Zfrp8* KD (Knock Down) ovaries and in germ stem cell (GSC) clones, in which the Zfrp8 protein had been silenced. The argument that strongly supports the role of Zfrp8 in the piRNA pathway is that its reduction affects the expression of the transposable elements in the ovaries ([@ref110]), as also seen in animals, that are mutant for the member of the piRNA pathway. Notably, dFmr1 was found as a component of the Zfrp8 protein complex together with Nufip (nuclear FMRP interacting protein) and Trailer hitch (Tral) ([@ref110]). Both these proteins were already identified as dFmr1 interactors: Nufip is one of the known interactors of FMRP in mammals ([@ref14]), whereas Tral is a component of the RNP granules in *Drosophila* neurons ([@ref12]). Zfrp8 may have a role in the early assembly of ribosomes with translational repressors and, as a consequence, influences different processes during oogenesis, including transposons silencing ([@ref172]). Very intriguingly, Hsp83, a known component of piRNA-mediated silencing pathway in the *Drosophila* gonads ([@ref164]; [@ref58]; [@ref172]), was found in the Zfrp8 complex as well ([@ref172]).

Finally, the TDP-43 protein involved in amyotrophic lateral sclerosis (ALS) also interacts with dFmr1. The physical association of these two proteins in ribonucleoproteic complexes was observed *in vivo*, in an ALS *Drosophila* model, and *in vitro*, in neuronal derived cells. FMRP deficit causes developmental defects and autistic behavior, whereas lack of TDP-43 leads to age-dependent neurodegeneration ([@ref54]; [@ref191]; [@ref40], [@ref39]; [@ref102]). The unexpected link between TDP-43 and FMRP opens novel perspectives to understand the physiopathological mechanisms underlying these seemingly different pathologies.

piRNA and TEs in the Nervous System {#sec6}
-----------------------------------

Although piRNAs were first identified in the gonads of mouse and *Drosophila* as regulators of transposable elements and repetitive sequences ([@ref62]; [@ref67]; [@ref180]; [@ref183]; [@ref68]; [@ref122]; [@ref94]; [@ref103]), a specific set of piRNAs was found in the mouse hippocampus and in neuronal cultures ([@ref92]). In addition, [@ref61] identified small RNA molecules in *Drosophila* heads displaying features resembling piRNAs (piRNA-like RNA molecules, pil-RNAs) ([@ref61]). More recently, piRNAs with a role in the regulation of learning-related synaptic plasticity were also identified in the nervous system of *Aplysia* ([@ref140]). These discoveries represented the starting point for studies demonstrating the presence of piRNAs in somatic tissues and in particular in the brain of several organisms including *Drosophila* and humans ([@ref11]; [@ref174]; [@ref133]; [@ref144]; [@ref145]; [@ref184]). Furthermore, RNA-seq analyses revealed the presence of thousands of retrotransposon-derived piRNA-like molecules as well as the presence of factors, involved in the piRNA biogenesis, such as Mili and Maelstrom in hippocampal mammalian neurons. Mice lacking one or the other protein exhibit defects in locomotor activity and behavior ([@ref105]; [@ref120]). The presence of piRNAs in the nervous system suggests a role in the transposon silencing and hence in genome stability, which may impact on brain heterogeneity, aging, and also neurological diseases. Using different organisms, it was demonstrated that the deregulated expression of the transposable elements can induce their mobilization, which causes *de novo* insertions in the genome and hence triggers genomic variability in neuronal cells ([@ref117]; [@ref38]; [@ref11]; [@ref53]; [@ref140]; [@ref133]; [@ref145]; [@ref184]; [@ref179]; [@ref78]).

Long-interspersed line-1 element (L1) is the only active element in the human genome ([@ref17]) and can transpose in the neuronal precursor stem cells of the rat hippocampus. The new insertions were found in neuronal protein coding genes ([@ref117]). Engineered human L1 *in vitro* mobilization was also reported in neuronal precursor cells isolated from human fetal brains and embryonic stem cells. These discoveries strongly suggest that L1-mediated transposition has the potential to contribute to genotypic variation in neurons.

Whole genome sequencing and the analysis of the new insertions of a *gypsy*-construct support the idea that piRNA-mediated transposition also triggers cellular heterogeneity in the neurons of the *Drosophila* mushroom bodies, which are considered as the functional homolog of the mammalian hippocampus ([@ref133]; [@ref133]). The mobilization of the TEs occurs in a specific neuronal population, the αβ neurons, which contain a lower amount of Aub and Ago3 compared to the γδ neurons ([@ref133]), raising the concrete hypothesis that transposition may have a functional role in brain physiology. More recent data, however, do not seem to confirm the correlation between the increment in the expression of TEs and new integration sites in aging ([@ref176]).

Clearly, the field is still very young and more studies will be required to firmly reach a consensus. However, even though the number of new genomic insertions does not exactly correlate with that expected from the remarkable increment of TE expression, a role of transposition in the nervous system must be considered, due to the growing amount of data on the topic.

Recent reports from many laboratories, conducted in *Drosophila*, in postmortem human tissues and in mammalian cells, support the relation between retrotransposition and neurological disorders ([@ref118]; [@ref49]; [@ref95]; [@ref171]; [@ref139]; [@ref89]; [@ref114]; [@ref136]; [@ref55]; [@ref69]; [@ref157]). Significant examples are reported below. Parkinson's disease (PD) is a neurodegenerative disorder that strongly affects movements. Aging represents a risk factor for the occurrence of sporadic PD ([@ref104]). piRNAs and piRNA-like molecules are differentially expressed in "induced Pluripotent Stem Cells" (iPSCs) from patients during differentiation ([@ref154]).

Alzheimer disease (AD) is the neurodegenerative disorder that represents the most common cause of dementia. As a remarkable feature, the analysis of postmortem brains from Alzheimer patients reveals the presence of misfolded proteins, namely the β-amyloid peptide and the Tau protein. In addition, transposable elements are also deregulated in these tissues compared with normal brains and in adult brains of *Drosophila* expressing human Tau protein associated with AD ([@ref137]; [@ref147]; [@ref69]). Intriguingly, the Tau-induced neurological phenotypes can be partially rescued by manipulating DNA damage response key factors, providing a further link between transposition, genomic instability, and DNA ([@ref69]).

Amyotrophic lateral sclerosis and frontotemporal dementia (FTD) are neurological disorders exhibiting a specific phenotypic spectrum causing dementia and cognitive impairment. They have been associated to a defect in TAR-DNA-binding protein 43 (TDP-43) ([@ref49]; [@ref96]; [@ref136]). Retrotransposition of one of the peculiar TEs with a functional similarity to viruses possessing also a "capsid," whose name is *gypsy*, has been associated to ALS and FTD in a model expressing human TDP-43 ([@ref89]). Even in the model of ALS, the modulation of DNA damage response (DDR) factors partially rescues the neurological phenotypes as occurs in Alzheimer's disease model.

Finally, Fragile-X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurological disorder associated to the premutation in the *Fmr1* gene reported before (expansion up to 90 RGG repeats in the regulatory region) ([@ref6]; [@ref88]). Transgenic *Drosophila* lines that carry the FXTAS-associated expansion exhibit an increased expression of *gypsy*, hence providing the first link between the activation of transposons and neurodevelopmental disorders ([@ref171]).

DNA Damage Response and Fragile-X in *Drosophila* and Mammals {#sec7}
=============================================================

Damage to DNA can arise for different reasons and can generate multiple lesions including single- and double-strand breaks (SSBs and DSBs). These lesions set in motion the DNA repair machine that repairs the damage and prevents massive genome instability. This involves changes in the chromatin structure and cell cycle arrest.

Different factors are sequentially involved in the repairing process like the MRN complex, which is a eukaryotic protein complex consisting of [M]{.ul}re11, [R]{.ul}ad 50 and [N]{.ul}bs1 proteins, followed by the ATM kinase, in turn phosphorylating several targets including p53 Chk2, BRCA1, and the key histone variant H2AX in mammals ([@ref99]; [@ref106]; [@ref91]; [@ref32]). Proteins and processes participating in "[D]{.ul}NA [D]{.ul}amage [R]{.ul}esponse" (DDR) cascade are conserved during evolution. In *Drosophila*, the majority of the information comes from studies on the meiotic checkpoint in ovaries, whose defects affect the fate of the embryonic dorsal cells ([@ref60]; [@ref1]; [@ref165]; [@ref36]). Females displaying defects in this checkpoint process produce embryos with fused dorsal appendages and the mutations affect the so-called spindle class genes ([@ref65]).

Interestingly, piRNA mutants also display defects in embryonic axis specification, which are thought to be a consequence of DNA damage mediated by the activation of transposable elements ([@ref30]; [@ref86]; [@ref128] [@ref87]). Mutations in *aub* and in other genes of the piRNA pathway such as *armitage* ([@ref34]), *spindle-E* ([@ref166]), *zucchini*, and *squash* ([@ref128]), which belong to the spindle class genes, lead to the accumulation of the H2Av histone variant ([@ref86]).

DDR, Transposons, and Neurological Diseases {#sec8}
-------------------------------------------

DNA lesions have been linked to neuronal decline in aging, oxidative stress conditions, and in neurological diseases ([@ref57]; [@ref2]; [@ref100]; [@ref142]; [@ref44]), even though the underlying molecular mechanisms remain poorly understood. Recently, the hyperactivation of the PARP-mediated DNA repair of single-strand breaks has been reported to be associated with neurodegeneration and ataxia in humans and mice ([@ref123]; [@ref83]; [@ref72]).

As described above, transposable elements represent a considerable fraction of the eukaryotic genome and are regulated by the small RNA pathways, in particular the piRNA pathway. Defects in the small RNA-mediated regulation trigger their activation in the germline and in the somatic tissues of the *Drosophila* gonads, hence generating genome instability ([@ref151]; [@ref82]; [@ref180]; [@ref30]; [@ref128]; [@ref164]; [@ref134]). A strong correlation between transposon mobilization and the DNA damage response also exists in human cells where the insertion of the Line-1 non-LTR retrotransposon depends on the DNA repair machine ([@ref18]; [@ref59]). In addition, enhanced L1 mobilization has been reported in ataxia telangiectasia, a neurological disorder due to mutations in the ATM gene implicated in DNA repair ([@ref37]). These observations, linking the transposable elements and the DNA damage response, have led to the hypothesis that DNA breaks accumulate in piRNA mutants, where the transposons are massively activated ([@ref87]). This opens novel perspectives in understanding the causes of devastating neurological diseases, which, in the long term, will result in better therapeutical targets.

DDR Has a Physiological Role in Neuronal Development {#sec9}
----------------------------------------------------

Emerging evidence support the hypothesis that activation of the DDR mediated by the double-strand breaks plays a physiological role in neuronal activity, by promoting the expression of the so-called early response genes in mice ([@ref101]). In neurons, the "early-response genes" code for transcription factors that are activated soon after the stimulation and regulate the cellular response by activating the expression of the "late response genes" ([@ref186]). The "early" genes play a key role in synapse development and maturation and are hence required for learning and memory ([@ref132]). [@ref101] demonstrated that DSBs occur after neuronal activity at the transcriptional start sites of the early genes (and are related to the TopoII β activity). This facilitates the rapid response of these genes, whose promoters are bound to the "paused" RNA pol II in basal condition, that is, in the absence of stimuli ([@ref85]). It is interesting to note that RNA pol II pausing is also observed at the promoters of genes that are expressed in response to environmental stimuli, and these genes are targeted by the *Drosophila* "HSP90 chaperone" ([@ref152]). This finding represents an intriguing link among "early" gene activation, HSP90, and DNA breaks.

The activation/movement of the transposable elements in the nervous system may induce genome instability, which in turn could connect DDR machinery and synaptic activity.

dFmr1/FMRP Has a Role in the DNA Damage Response {#sec10}
------------------------------------------------

FMRP may have a crucial role in this scenario because it has been related to the DNA damage response. Liu and collaborators demonstrated that *dfmr1* mutant flies display disproportioned cell death, related to DNA breaks and to marked genome instability, upon inducing DNA lesions ([@ref97]). dFmr1 and FMRP had been previously shown to regulate cell cycle progression and differentiation in the germline as well as in the brain ([@ref52]; [@ref190]; [@ref27]; [@ref129]), exerting their function in the early DDR through its Agenet and KH domains ([@ref194]). Soon after this observation, a result in mouse also supported a role of FMRP in the DNA damage response, regulating H2Ax phosphorylation, BRCA complex formation, and accumulation in embryonic fibroblasts and in mouse spermatocyte ([@ref5]). This role is thought to be independent of the canonical function in the translational control of mRNAs involved in the synaptic plasticity ([@ref26]; [@ref124]; [@ref15]) and requires FMRP N-terminal Tudor/Agenet domain for its binding to the H3 histone ([@ref5]). All these discoveries assign a role to FMRP/dFmr1 in the DDR cascade, identifying this multifaceted protein as a hub for multiple cellular processes. Clearly, one of the most exciting and difficult features of FMRP is the presence of multiple domains involved in a variety of molecular processes, from the nuclear localization domain, the RNA-binding domains, and the Tudor/Agenet domain. This implies that a single protein has distinct roles depending on its localization in the different subcellular compartments. Future efforts will aim at disentangling the diverse functions of this molecular "Swiss knife" in development and physiology.

Conclusions and Future Perspectives {#sec11}
===================================

A growing number of studies report the identification of piRNAs, piRNA-related proteins, and piRNA-mediated transposition as key factors ensuring heterogeneity in mammalian neurons. Transposable elements are indeed emerging as novel players in neuronal development, and they may function through the DNA damage response pathway. In parallel, it has been shown that the *Drosophila* ortholog of the Fragile-X gene in humans, *dFmr1*, interacts with 4 of 5 Argonaute proteins in the gonads and in somatic tissues ([@ref29]; [@ref76]; [@ref24]; [@ref79]) and plays a role in the piRNA-mediated silencing of the repetitive sequences and transposon in the gonads ([@ref24]; [@ref163]). [Figure 5](#fig5){ref-type="fig"} illustrates the potential role of dFmr1 in the protein network involved in genome stability. These discoveries open new perspectives for understanding the role and the mode of action of the dFmr1 protein in genome stability and pave the way to address its role in the piRNA pathway operating in the nervous system.

![Scheme displaying the network of genetic and biochemical interactors of dFmr1 related to its role in genome stability. The tissues in which the genetic and/or biochemical interaction occurs are indicated (see text). Cup and Nufip are indicated by a dotted line, because they have not been yet tested for their role in the piRNA-mediated silencing of TEs. Hsp83 is connected to dFmr1 by a dotted line, because its interaction has not yet been demonstrated. Asterisks indicate the proteins that are part of the polar granules.](fgene-10-00010-g005){#fig5}

Key questions need now to be addressed: Does dFmr1 has a piRNA-mediated role in the brain and, if so, does its role in genome stability account for the multiple neurological phenotypes exhibited by *dFmr1* mutants and by the FraX patients? Typically, is the dFmr1 pathway linked to piRNAs involved in synaptic plasticity, learning and memory, and circadian behaviors? Should this role of dFmr1 be exerted in a specific temporal window during development as suggested by recent studies? ([@ref185]; [@ref47]; [@ref48]).

*Drosophila* represents an attractive model for studying the Fragile-X syndrome and will help to address these questions because of the short generation time; the different types of genetic, cellular and molecular tools available; and the easy phenotype evaluation and rescue. *Drosophila melanogaster* offers a suitable *in vivo* model to prescreen numerous potential therapeutic molecules ([@ref109]; [@ref31]; [@ref75]; [@ref70]), and clinical trials have been performed in human FraX patients, even though the results are not convincing. If the role of dFmr1 in the piRNA-mediated regulation of transposons is confirmed in the nervous system as well, new therapeutic possibility will open up. We are confident that dFmr1/FMRP will still surprise us and will help us in searching and finding potential therapeutical targets for the treatment of this devastating disease.
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